"Cervia II working group report 2006": guidelines on diagnosis and treatment of Helicobacter pylori infection in Italy

Caselli, M., Zullo, A., Maconi, G., Parente, F., Alvisi, V., Casetti, T., Sorrentino, D. and Gasbarrini, G. (2007) "Cervia II working group report 2006": guidelines on diagnosis and treatment of Helicobacter pylori infection in Italy. Digestive and Liver Disease, 39 8: 782-789. doi:10.1016/j.dld.2007.05.016


Author Caselli, M.
Zullo, A.
Maconi, G.
Parente, F.
Alvisi, V.
Casetti, T.
Sorrentino, D.
Gasbarrini, G.
Title "Cervia II working group report 2006": guidelines on diagnosis and treatment of Helicobacter pylori infection in Italy
Journal name Digestive and Liver Disease   Check publisher's open access policy
ISSN 1590-8658
1878-3562
Publication date 2007-08-01
Sub-type Article (original research)
DOI 10.1016/j.dld.2007.05.016
Volume 39
Issue 8
Start page 782
End page 789
Total pages 8
Place of publication London, United Kingdom
Publisher WB Saunders Co.
Language eng
Formatted abstract
Proper management of Helicobacter pylori infection in clinical practice – when supported by evidence-based data – is expected to produce substantial cost-efficacy advantages. This consideration has prompted the Cervia Working Group to organise a meeting of experts to update the National Guidelines on the diagnosis and treatment of H. pylori infection in Italy. Recommendations in the new European Guidelines were considered in the National setting, here in the light of factors such as the incidence of gastric cancer and gastric lymphoma, the accessibility to different diagnostic tools, the prevalence of bacterial resistance against antibiotics, and the availability of different drugs. The main revisions in respect to the previous guidelines include H. pylori eradication in non-ulcer dyspepsia patients and in non-steroidal, anti-inflammatory drug users, as well as in patients with idiopathic thrombocytopenic purpura and iron deficiency anaemia. The stool antigen test is now accepted as a valid test for confirmation of H. pylori eradication following therapy. New therapeutic approaches have been recommended for both first- (sequential therapy) and second-line (levofloxacin-based) treatment in our country.
Keyword Consensus meeting
Diagnosis
Guidelines
Helicobacter pylori
Treatment
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status Non-UQ

Document type: Journal Article
Sub-type: Article (original research)
Collection: School of Medicine Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 80 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 26 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Tue, 12 Feb 2013, 21:22:49 EST by System User on behalf of Scholarly Communication and Digitisation Service